Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × avelumab × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 3 NET 1 Lymphoid 1

Conditions

Lymphoma 3 Lymphoma, Follicular 2 Sezary Syndrome 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Hodgkin Disease 1 Central Nervous System Neoplasms 1 Carcinoma, Neuroendocrine 1 Cancer That is Associated With a Chronic Viral Infection 1

Interventions

pembrolizumab 1 avelumab 1 Fluorodeoxyglucose F18 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03147404 2019-12-30

MS100070-0177

Samsung Medical Center

Phase 2 Completed

EndocrineLymphoid

Lymphoma, Follicular, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡